BioSpace News Archive

Biotech Bay

ArsenalBio to Participate in Upcoming Investor Conferences

ArsenalBio today announced that Company leadership will participate in two upcoming virtual investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference Format: On-Demand Presentation Date: November 29 – December 2, 2021.

November 19, 2021
·
1 min read
Genetown

EyePoint Pharmaceuticals Announces Closing of $115.4 Million Public Offering

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), today announced the closing of the previously announced underwritten public offering of 5,122,273 shares of its common stock.

November 19, 2021
·
4 min read
Genetown

Vor to Participate in Piper Sandler 33rd Virtual Annual Healthcare Conference

Vor Biopharma will be participating at the Piper Sandler 33rd Virtual Annual Healthcare Conference. Piper Sandler 33rd Virtual Annual Healthcare Conference Date: Tuesday, November 30 through Thursday, December 2, 2021.

November 19, 2021
·
1 min read
Biotech Beach

Ambrx Biopharma Inc. Announces Acceptance of Two Poster Presentations at the 2021 San Antonio Breast Cancer Symposium

Ambrx Biopharma Inc. today announced the publication of two abstract poster presentations to be conducted at the 2021 San Antonio Breast Cancer Symposium (SABCS), which is being held from December 7-10, 2021.

November 19, 2021
·
2 min read
BioMidwest

Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level.

November 19, 2021
·
2 min read
Deals

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics, Inc. today announced that on November 18, 2021 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 168,575 shares of Iovance’s common stock to seven new non-executive employees.

November 19, 2021
·
5 min read
Business

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

Acer Therapeutics Inc. today reported financial results for the third quarter ended September 30, 2021 and provided an update on Acer’s recent corporate developments.

November 19, 2021
·
11 min read
Deals

Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.

Merck today announced the successful completion of the cash tender offer, through a subsidiary, Astros Merger Sub, Inc., for all of the outstanding shares of common stock of Acceleron Pharma Inc.

November 19, 2021
·
3 min read